Home Research Series
Strategies ECM & IPO Index Rebalance Event-Driven Equity Bottom-Up Thematic Markets Greater China Other APAC US
About Team Contact Us
ECM

TenNor Therapeutics (丹诺医药) IPO Trading

21 May 2026 By Ke Yan, CFA, FRM
← All Research ReportsMore ECM coverage →

Abstract: TenNor Therapeutics raised HKD 598.3m (USD 76.9m) from its global offering and will list on the Hong Kong Stock Exchange on Friday, May 22, 2026. In our previous notes, we looked at the company's fundamentals and the valuation. In this note, we provide an update for the IPO before its trading debut.

7630 HK (7630 HK)

Highlighted Stocks

7630 HK

About IPO Trading

Notes on the trading dynamics before debut for newly listed Hong Kong shares. All issues of IPO Trading →

Related Reports

More from IPO Trading

Interested in the full report? Get in touch with our team.

Request Full Report

We will review your request. Once approved, the report will be sent to your company email.

Report: TenNor Therapeutics (丹诺医药) IPO Trading
Date: 21 May 2026

Request Received!

Thank you! We will review your request and email the report to you, usually within 1 business day.